blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2342197

EP2342197 - RADIOLABELLED INHIBITORS OF THE GLYCINE 1 TRANSPORTER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.11.2013
Database last updated on 24.08.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2011/28]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / ALBERATI, Daniela
Kirchplatz 4
CH-4800 Zofingen / CH
02 / BORRONI, Edilio Maurizio
Dammerkirchstrasse 70
CH-4056 Basel / CH
03 / HARTUNG, Thomas
Schlossstrasse 15C
79541 Loerrach / DE
04 / NORCROSS, Roger
Rheinfelderstrasse 2
CH-4305 Olsberg / CH
05 / PINARD, Emmanuel
7 rue de Pujo
F-68480 Linsdorf / FR
 [2011/35]
Former [2011/28]01 / ALBERATI, Daniela
Kirchplatz 4
CH-4800 Zofingen / CH
02 / BORRONI, Edilio Maurizio
Vogesenstrasse 108
CH-4056 Basel / CH
03 / HARTUNG, Thomas
Schlossstrasse 15C
79541 Loerrach / DE
04 / NORCROSS, Roger
Rheinfelderstrasse 2
CH-4305 Olsberg / CH
05 / PINARD, Emmanuel
7 rue de Pujo
F-68480 Linsdorf / FR
Representative(s)Poppe, Regina
F.Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2013/03]Poppe, Regina
F.Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Former [2011/28]Poppe, Regina
F.Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date09737459.926.10.2009
[2011/28]
WO2009EP64033
Priority number, dateEP2008016822904.11.2008         Original published format: EP 08168229
[2011/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010052143
Date:14.05.2010
Language:EN
[2010/19]
Type: A1 Application with search report 
No.:EP2342197
Date:13.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 14.05.2010 takes the place of the publication of the European patent application.
[2011/28]
Type: B1 Patent specification 
No.:EP2342197
Date:16.01.2013
Language:EN
[2013/03]
Search report(s)International search report - published on:EP14.05.2010
ClassificationIPC:C07D405/10, A61K51/00
[2011/28]
CPC:
C07D405/10 (EP,US); C07D405/04 (KR); A61K51/04 (KR);
A61P25/00 (EP); A61P25/18 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P43/00 (EP); G01N33/60 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/28]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:RADIOAKTIV MARKIERTE INHIBITOREN DES GLYCIN-1-TRANSPORTERS[2011/28]
English:RADIOLABELLED INHIBITORS OF THE GLYCINE 1 TRANSPORTER[2011/28]
French:INHIBITEURS RADIOMARQUÉS DES TRANSPORTEURS 1 DE LA GLYCINE[2011/28]
Entry into regional phase06.06.2011National basic fee paid 
06.06.2011Designation fee(s) paid 
06.06.2011Examination fee paid 
Examination procedure19.05.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.06.2011Examination requested  [2011/28]
08.03.2012Despatch of a communication from the examining division (Time limit: M04)
09.06.2012Reply to a communication from the examining division
20.08.2012Communication of intention to grant the patent
05.12.2012Fee for grant paid
05.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.03.2012
Opposition(s)17.10.2013No opposition filed within time limit [2013/52]
Fees paidRenewal fee
10.10.2011Renewal fee patent year 03
05.10.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY16.01.2013
EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
MK16.01.2013
MT16.01.2013
RO16.01.2013
SK16.01.2013
SM16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
[2015/41]
Former [2015/32]CY16.01.2013
EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
MK16.01.2013
RO16.01.2013
SK16.01.2013
SM16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2015/24]CY16.01.2013
EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
RO16.01.2013
SK16.01.2013
SM16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2014/25]CY16.01.2013
EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
RO16.01.2013
SK16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/52]CY16.01.2013
EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
RO16.01.2013
SK16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/49]EE16.01.2013
FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
RO16.01.2013
SK16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/41]FI16.01.2013
HR16.01.2013
LT16.01.2013
LV16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/40]FI16.01.2013
LT16.01.2013
LV16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/38]FI16.01.2013
LT16.01.2013
LV16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
Former [2013/37]FI16.01.2013
LT16.01.2013
BG16.04.2013
NO16.04.2013
GR17.04.2013
IS16.05.2013
Former [2013/34]LT16.01.2013
BG16.04.2013
NO16.04.2013
IS16.05.2013
Former [2013/33]LT16.01.2013
NO16.04.2013
Cited inInternational search[A]WO2006082001  (HOFFMANN LA ROCHE [CH], et al) [A] 1-13 * compounds of formula I A;;; claim 2 *;
 [AD]WO2007041025  (MERCK & CO INC [US], et al) [AD] 1-13* claims 1-20 *
Examination   - ANTHONY D GEE, BRITISH MEDICAL BULLETIN, (2003), vol. 65, pages 169 - 177
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.